LIMCR

The LIMCR

The LIMCR (Laboratory for Immunological and Molecular Cancer Research), which is integrated in the Third Medical Department of the Paracelsus Medical University Hospital, opened its doors in 2005 and has its research focus on chronic lymphocytic leukemia (CLL), myelodysplastic syndromes (MDS) and acut myeloid leukemia (AML). The LIMCR maintains a close connection with the clinic to ensure maximum synergy and efficacy in cancer therapy.

Our research focus

PLEASE DONATE NOW!

Support our initiative to fight cancer! 

 

With your donation you make an important contribution to cancer research at the Salzburg Cancer Research Institute (SCRI) at the University Hospital Salzburg.

DONATE NOW
DONATE NOW

Research Groups

Murine-Lymphoma Models

Group leader: PD Dr. Alexander Egle

“The complexity of the disease can be mimicked in the murine model. In this system we are analyzing the effect of novel therapy concepts and the communication of leukemic cells with the immune system.”

Tumor immunology

Group leader: Priv.-Doz. Dr. Roland Geisberger

“Leukemic cells benefit from deactivating other immune cells. We study the underlying mechanisms and search for ways to reactivate the immune system to combat leukemia.”

Myeloid Neoplasias

Group leader: PD Dr. DI Lisa Pleyer

“Our aim is to better understand how we can use targeted immune therapies to help the body to eliminate myeloid cancer cells”

Immuno-oncology

Group leader: Priv.-Doz. Dr. Nadja Zaborsky

``In our working group, we are analyzing the interplay between genetic changes in cancer cells and alterations in immune cell composition and functionality, which is important to improve current immune therapy approaches.``

News

Tricked the cancer 2.0

Pressearticle November 2018

Prim. Univ.Prof. Dr. Richard Greil, UK für Innere Medizin III der PMU | Salzburger Nachrichten

LIMCR
2019-11-11T11:20:52+01:00
Pressearticle November 2018 Prim. Univ.Prof. Dr. Richard Greil, UK für Innere Medizin III der PMU | Salzburger Nachrichten More
0
LIMCR

Tricked the cancer

Pressearticle November 2018

Prim. Univ.Prof. Dr. Richard Greil, UK für Innere Medizin III der PMU | Salzburger Nachrichten

LIMCR
2019-11-11T11:19:30+01:00
Pressearticle November 2018 Prim. Univ.Prof. Dr. Richard Greil, UK für Innere Medizin III der PMU | Salzburger Nachrichten More
0
LIMCR

Sie haben ein Anliegen oder Fragen?

Feel free to contact us – we will get back back to you as soon as possible.

Contact us